Skip to content
20-F

Annual Report (Foreign)

Freeline Therapeutics Holdings plc

0000950170-23-011688

← back to feed
Filed
Apr 4, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2022 · Dec 31, 2022 59.27M sh
Shares Diluted FY 2022 · Dec 31, 2021 35.7M sh
Shares Diluted FY 2022 · Dec 31, 2020 14.15M sh
Shares Outstanding FY 2022 · Dec 31, 2022 65.11M sh
Capex FY 2022 · Dec 31, 2022 $7.01M
Capex FY 2022 · Dec 31, 2021 $4.27M
Capex FY 2022 · Dec 31, 2020 $2.51M
Operating Cash Flow FY 2022 · Dec 31, 2022 −$78.22M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$107.56M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$94.97M
Cash And Equivalents FY 2022 · Dec 31, 2022 $47.28M
Cash And Equivalents FY 2022 · Dec 31, 2021 $117.66M
Cash And Equivalents FY 2022 · Dec 31, 2020 $229.97M
Stockholders Equity FY 2022 · Dec 31, 2022 $52.41M
Stockholders Equity FY 2022 · Dec 31, 2021 $120.44M
Stockholders Equity FY 2022 · Dec 31, 2020 $249.8M
Stockholders Equity FY 2022 · Dec 31, 2019 $84.96M
Current Liabilities FY 2022 · Dec 31, 2022 $30.97M
Current Liabilities FY 2022 · Dec 31, 2021 $20.68M
Total Liabilities FY 2022 · Dec 31, 2022 $34.23M
Total Liabilities FY 2022 · Dec 31, 2021 $20.68M
Current Assets FY 2022 · Dec 31, 2022 $67.63M
Current Assets FY 2022 · Dec 31, 2021 $128.29M
Total Assets FY 2022 · Dec 31, 2022 $86.64M
Total Assets FY 2022 · Dec 31, 2021 $141.13M
Eps Diluted FY 2022 · Dec 31, 2022 −$1.50
Eps Diluted FY 2022 · Dec 31, 2021 −$3.93
Eps Diluted FY 2022 · Dec 31, 2020 −$6.81
Eps Basic FY 2022 · Dec 31, 2022 −$1.50
Eps Basic FY 2022 · Dec 31, 2021 −$3.93
Eps Basic FY 2022 · Dec 31, 2020 −$6.81
Sga Expense FY 2022 · Dec 31, 2022 $30.66M
Sga Expense FY 2022 · Dec 31, 2021 $44.57M
Sga Expense FY 2022 · Dec 31, 2020 $26.3M
Rd Expense FY 2022 · Dec 31, 2022 $66.2M
Rd Expense FY 2022 · Dec 31, 2021 $95.43M
Rd Expense FY 2022 · Dec 31, 2020 $76.15M
Net Income FY 2022 · Dec 31, 2022 −$88.97M
Net Income FY 2022 · Dec 31, 2021 −$140.39M
Net Income FY 2022 · Dec 31, 2020 −$96.32M
Operating Income FY 2022 · Dec 31, 2022 −$98.45M
Operating Income FY 2022 · Dec 31, 2021 −$142.38M
Operating Income FY 2022 · Dec 31, 2020 −$102.45M